R&D Strategy

AKLRD is committed to transforming patient’s lives through innovation and is changing the way drugs are developed by seeking inspiration from nature to combat some of the biggest challenges facing modern medicine today.

AKLRD’s groundbreaking approach has allowed us to identify secondary metabolites of plant origin with proven efficacy and safety. These metabolites are then synthesized before undergoing standard pharmaceutical clinical development.

This novel approach has already resulted in AKL4 [APPA], an investigational medicine showing great promise in the treatment of osteoarthritis, a common and devastating disease with limited treatment options and no cure.

We welcome enquiries from potential investors and partners in this development and commercialisation process.